FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly urology. It is ensured by introduction of Blemaren in a dose 2 g in the morning and in the evening after meal with water or juice with increased level of uric acid in blood more than 0.472 mmol/l, and pH of urine 6.2-6.8. Introduction is carried out for 2 months in spring and autumn.
EFFECT: method provides fast normalisation of the content of uric acid in blood, daily urine, and decreased uraturia.
4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION AND COMPLEX TREATMENT OF UROLITHIASIS AFTER DISTANT LITHOTRIPSY | 2010 |
|
RU2419427C1 |
| PREPARATION FLAVOSUCCINE FOR TREATING AND PREVENTING RENAL AND URINARY DISEASES | 2010 |
|
RU2456011C1 |
| METHOD FOR REHABILITATION OF PATIENTS WITH RENAL DISEASE | 1999 |
|
RU2177324C2 |
| METHOD FOR CORRECTING METABOLIC DISORDERS IN CHILDREN WITH DISMETABOLIC NEPHROPATHIES | 2000 |
|
RU2190413C2 |
| AGENT FOR PROPHYLAXIS AND TREATMENT OF UROLITHIASIS DISEASE | 2002 |
|
RU2205655C1 |
| METHOD OF TREATING OXALATE NEPHROPATHY IN CHILDREN | 2020 |
|
RU2738552C1 |
| METHOD FOR SELECTING THERAPY FOR CORRECTING LIPID METABOLISM DISORDERS IN CHRONIC PYELONEPHRITIS PATIENTS | 2005 |
|
RU2310864C2 |
| TEA FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 1992 |
|
RU2026079C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE C3-C5 AT DIALYSIS STAGE, EXCLUDING PYELONEPHRITIS, UROLITHIASIS | 2017 |
|
RU2646467C1 |
| METHOD FOR CHOOSING TACTICS FOR TREATING PATIENTS WITH PURINE EXCHANGE DISORDERS | 2003 |
|
RU2273032C2 |
